Gene expression profile of human colon cancer cells treated with cross-reacting material 197, a diphtheria toxin non-toxic mutant

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 3, 2011, Pages 639-649

  Rivetti, S ^a,b   Lauriola, M ^a,b   Voltattorni, M ^a   Bianchini, M ^c   Martini, D ^a   Ceccarelli, C ^a   Palmieri, A ^d   Mattei, G ^a,b   Franchi, M ^a   Ugolini, G ^a   Rosati, G ^a   Montroni, I ^e   Taffurelli, M ^a   Solmi, Rosella ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Centro di Ricerca in Genetica Molecolare Fondazione CARISBO   (Italy)

^c Centro de Investigaciones Oncologicas FUCA   (Argentina)

^d UNIVERSITY OF FERRARA   (Italy)

^e Dipartimento di Istologia Embriologia e Biologie Applicata   (Italy)

Author keywords

Colon cancer; CRM197; Microarray

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BUTYROPHILIN SUBFAMILY 2 MEMBER A1; COMPLEMENTARY DNA; DIPHTHERIA TOXIN; DIPHTHERIA TOXOID CRM197; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; GUANINE NUCLEOTIDE BINDING PROTEIN G SUBUNIT ALPHA 1; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PROTEIN PHOSPHATASE 2 CATALYTIC SUBUNIT ALPHA ISOZYME; UNCLASSIFIED DRUG; ACTIN RELATED PROTEIN; ACTIN RELATED PROTEIN 1 HOMOLOG A; ACTIVATING TRANSCRIPTION FACTOR; ACTIVATING TRANSCRIPTION FACTOR 7; CLEAVAGE AND POLYADENYLATION SPECIFIC FACTOR 3; F BOX PROTEIN; FBXO3 PROTEIN; FIBULIN 5; FNDC4 PROTEIN; KARYOPHERIN ALPHA; KARYOPHERIN ALPHA 4; KPNB1 PROTEIN; MUSCARINIC M1 RECEPTOR; PAX INTERACTING WITH TRANSCRIPTION ACTIVATION DOMAIN PROTEIN 1; PCBP1 PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2 CATALYTIC SUBUNIT ALPHA ISOZYME; PHOSPHORYLASE KINASE GAMMA 2; PROTEIN; RECQ HELICASE; RETENTION IN ENDOPLASMIC RETICULUM 1; VACUOLAR PROTEIN SORTING 41; ZINC FINGER AND BTB DOMAIN CONTAINING 17; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 415; ZINC FINGER PROTEIN 486;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING COMPETITION; CANCER CELL CULTURE; CELL CYCLE REGULATION; CELL STRUCTURE; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SCANNING ELECTRON MICROSCOPY; CANCER MORPHOLOGY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONCENTRATION RESPONSE; DRUG EFFICACY; GENE EXPRESSION; GOLGI COMPLEX; IN VITRO STUDY; MICROVILLUS; MTT ASSAY; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RNA SPLICING; UPREGULATION;

EID: 80055120144     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400310     Document Type: Article

References (32)

1. Buzzi S, Maistrello I. Inhibition of growth of Erlich tumors in Swiss mice by diphtheria toxin. Cancer Res 1973; 33:2349-53.
2. Buzzi S. Diphtheria toxin treatment of human advanced cancer. Cancer Res 1982; 42:2054-8. (Pubitemid 12103411)
3. Buzzi S, Rubboli D, Buzzi G, Buzzi AM, Morisi C, Pironi F. CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients. Cancer Immunol Immunother 2004; 53:1041-8. (Pubitemid 39371748)
4. Giannini G, Rappuoli R, Ratti G. The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. Nucleic Acids Res 1984; 12:4063-9.
5. Mitamura T, Higashiyama S, Taniguchi N, Klagsbrun M, Mekada E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem 1995; 270:1015-9.
6. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251:936-9. (Pubitemid 21926188)
7. Miyamoto S, Yagi H, Yotsumoto F, Kawarabayashi T, Mekada E. Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy. Cancer Sci 2006; 97:341-7.
8. Kageyama T, Ohishi M, Miyamoto S, Mizushima H, Iwamoto R, Mekada E. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity. J Biochem 2007; 142:95-104. (Pubitemid 351455373)
9. Hashimoto K, Higashiyama S, Asada H, et al. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem 1994; 269:20060-6. (Pubitemid 24250928)
10. Freeman MR, Yoo JJ, Raab G, Soker S, Adam RM, Schneck FX, Renshaw AA, Klagsbrun M, Atala A. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 1997; 99:1028-36. (Pubitemid 27123640)
11. Raab G, Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1997; 1333:179-99.
12. Qiao J, Ghani K, Caruso M. Diphtheria toxin mutant CRM197 is an inhibitor of protein synthesis that induces cellular toxicity. Toxicon 2008; 51:473-7. (Pubitemid 351240964)
13. Kimura Y, Saito M, Kimata Y, Kohno K. Transgenic mice expressing a fully nontoxic diphtheria toxin mutant, not CRM197 mutant, acquire immune tolerance against diphtheria toxin. J Biochem 2007; 142:105-12. (Pubitemid 351455372)
14. Ichise T, Adachi S, Ohishi M, Ikawa M, Okabe M, Iwamoto R, Mekada E. Humanized gene replacement in mice reveals the contribution of cancer stroma-derived HB-EGF to tumor growth. Cell Struct Funct 2010; 35:3-13.
15. Yotsumoto F, Yagi H, Suzuki SO, et al. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun 2008; 365:555-61. (Pubitemid 350181687)
16. Solmi R, Lauriola M, Francesconi M, et al. Displayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines. BMC Cancer 2008; 8:227.
17. Yonezawa M, Wada K, Tatsuguchi A, et al. Heregulin-induced VEGF expression via the ErbB3 signaling pathway in colon cancer. Digestion 2009; 80:215-25.
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65:55-63. (Pubitemid 14203433)
19. Freshney R. Culture of animal cells: a manual of basic technique. In Technique. Fogh J, ed. Plenum Press NY and London. New York 1987.
20. Nusse M, Beisker W, Hoffmann C, Tarnok A. Flow cytometric analysis of G1- and G2/M-phase subpopulations in mammalian cell nuclei using side scatter and DNA content measurements. Cytometry 1990; 11:813-21. (Pubitemid 20303046)
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8. (Pubitemid 34164012)
22. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95:14863-8. (Pubitemid 29003722)
23. Pan B, Sengoku K, Goishi K, Takuma N, Yamashita T, Wada K, Ishikawa M. The soluble and membrane-anchored forms of heparin-binding epidermal growth factor-like growth factor appear to play opposing roles in the survival and apoptosis of human luteinized granulosa cells. Mol Hum Reprod 2002; 8:734-41.
24. Yagi H, Yotsumoto F, Sonoda K, Kuroki M, Mekada E, Miyamoto S. Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer. Int J Cancer 2009; 124:1429-39.
25. Bauer-Mehren A, Furlong LI, Sanz F. Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 2009; 5:290.
26. Rowinsky EK. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors. Annu Rev Med 2004; 55:433-57. (Pubitemid 38316736)
27. Antignani A, Youle RJ. Endosome fusion induced by diphtheria toxin translocation domain. Proc Natl Acad Sci USA 2008; 105:8020-5. (Pubitemid 351904700)
28. Guichard C, Pedruzzi E, Fay M, et al. Dihydroxyphenylethanol induces apoptosis by activating serine/threonine protein phosphatase PP2A and promotes the endoplasmic reticulum stress response in human colon carcinoma cells. Carcinogenesis 2006; 27:1812-27. (Pubitemid 44288663)
29. Yu LG, Packman LC, Weldon M, Hamlett J, Rhodes JM. Protein phosphatase 2A, a negative regulator of the ERK signaling pathway, is activated by tyrosine phosphorylation of putative HLA class II-associated protein I (PHAPI)/pp32 in response to the antiproliferative lectin, jacalin. J Biol Chem 2004; 279:41377-83. (Pubitemid 39313577)
30. Suki WN, Abramowitz J, Mattera R, Codina J, Birnbaumer L. The human genome encodes at least three non-allellic G proteins with alpha i-type subunits. FEBS Lett 1987; 220:187-92. (Pubitemid 17126533)
31. Jeong J, Rao AU, Xu J, Ogg SL, Hathout Y, Fenselau C, Mather IH. The PRY/SPRY/B30.2 domain of butyrophilin 1A1 (BTN1A1) binds to xanthine oxidoreductase: implications for the function of BTN1A1 in the mammary gland and other tissues. J Biol Chem 2009; 284:22444-56.
32. Clarke PA, Dickson JH, Harris JC, Grabowska A, Watson SA. Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor. Cancer Res 2006; 66:3504-12.